India CDMO Market: By Service (CRO, CMO, Packaging) and Country

Purchase Option

$ 3100
$ 4600
$ 6900

India CDMO Market size was valued at USD billion in 2022 and is expected to reach a value of USD billion by 2028, growing at a CAGR of 14.0% from 2022 to 2028. The market report provides a detailed overview of the Indian CDMO  Market, which has been segmented by application. Based on application, the India CDMO is segmented into CRO (Discovery, Preclinical, Clinical, Laboratory Services) and CMO (Finished Product Manufacturing, API Manufacturing, Packaging). According to precision business insights, the API Manufacturing segment is predicted to register the fastest growth rate during the forecast period.

India CDMO Market Key Development:

In May 2019, Catalent Inc. acquired Paragon Bio Services, a leader in Gene Therapy.

India CDMO Market Dynamics

The rising prevalence of chronic diseases and an increase in the geriatric population have boosted the demand for medical products with a shorter time to market, and quicker regulatory approval, which is expected to create demand for pharmaceuticals and the CDMO market in India.

India Cdmo Market Segmentation

By Service
  • CRO
  • CMO

Frequently Asked Questions

The india cdmo market is projected to expand at a CAGR of 14.0% during the forecast period.

The major players in the Indian CDMO market are ??? Albany Molecular Research Inc. (AMRI), Baxter, Covance Inc., PAREXEL International Corporation, Pharmaceutical Product Development LLC, Quanticate Ltd., SGS Life Science Services SA, Thermo Fisher Scientific Inc. (Patheon), Vetter, and Recipharm to name a few.

The India CDMO Market size was valued at USD billion in 2022

Key Features of the Reports

  • The india cdmo market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The india cdmo market report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The india cdmo market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The india cdmo market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The india cdmo market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. India CDMO Market Introduction
2.1. India CDMO Market - Taxonomy
2.2. India CDMO Market- Definitions
2.2.1. By Service
3. India CDMO Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. India CDMO Market Dynamic Factors - Impact Analysis
3.6. India CDMO Market  Competition Landscape
4. India CDMO Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. India CDMO Market, By Service, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. By CRO
5.1.1. Discovery
5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Preclinical
5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Clinical
5.1.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Laboratory Services
5.1.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.2. By CMO
5.2.1. Finished Product Manufacturing
5.2.1.1.  Injectables
5.2.1.1.1.        Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.1.1.2.        Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.1.3.        Market Opportunity Analysis
5.2.1.2. Solid Dosage Forms
5.2.1.2.1.        Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.1.2.2.        Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.2.3.        Market Opportunity Analysis
5.2.1.3. Others (Semisolids/liquid, powder)
5.2.1.3.1.        Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.1.3.2.        Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3.3.        Market Opportunity Analysis
5.2.2. API Manufacturing
5.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Packaging
5.2.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
6. Competition Landscape 
6.1. Strategic Dashboard of Top Market Players
6.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
6.2.1. Albany Molecular Research Inc. (AMRI)
6.2.2. Baxter
6.2.3. Covance Inc.
6.2.4. PAREXEL International Corporation
6.2.5. Pharmaceutical Product Development LLC
6.2.6. Quanticate Ltd.
6.2.7. SGS Life Science Services SA
6.2.8. Thermo Fisher Scientific Inc. (Patheon)
6.2.9. Vetter
6.2.10. Recipharm
7. Research Methodology
8. Key Assumptions and Acronyms
  • Albany Molecular Research Inc. (AMRI)
  • Baxter
  • Covance Inc.
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC
  • Quanticate Ltd.
  • SGS Life Science Services SA
  • Thermo Fisher Scientific Inc. (Patheon)
  • Vetter
  • Recipharm

Adjacent Markets